Forte Biosciences, Inc.

FBRX

Forte Biosciences, Inc.

FBRX

Insider Sentiment (TTM):

Last Purchase:2025-12-30Last Sale:-Shares Purchased (TTM):9,680Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:13,406,494Shares Outstanding:13,910,668Institutional Ownership Pct.:96.38%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	50	58	77	93	106	46	22	16	24	30	37	46
Assets Current
Assets Current	203	65	81	95	108	47	61	18	26	32	38	47
Short Term Investments	-	-	-	-	-	-	36	-	-	-	-	-
Prepaid Expense And Other Assets Current	5	7	4	2	1	1	3	1	1	1	1	1
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	3	2	2	2	0	0	0	0	0	0	1	1
Assets	206	67	83	97	108	47	62	18	26	32	39	48
Liabilities And Stockhold…
Accounts Payable Current	14	13	10	5	5	5	5	5	5	2	1	5
Liabilities Current
Accrued Liabilities Current	6	11	11	8	4	4	4	3	4	2	2	2
Liabilities Current	20	24	21	13	9	9	9	9	9	3	4	7
Accrued Income Taxes Noncurrent	-	-	1	-	-	-	-	-	-	-	-	-
Other Liabilities Noncurrent	2	1	-	-	-	-	-	-	-	-	-	-
Liabilities	22	25	22	-	-	-	9	-	-	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Stockholders Equity	184	42	61	84	99	38	52	9	17	29	35	40
Additional Paid In Capital Common Stock	453	288	284	283	280	208	206	156	155	155	154	153
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	-0	-	-	0	0	-0	-0	0	-0
Retained Earnings Accumulated Deficit	-269	-246	-223	-199	-181	-170	-154	-147	-138	-126	-119	-113
Related Party	-	-	-	-	-	0	-	-	0	-	-	-
Liabilities And Stockholders Equity	206	67	83	97	108	47	62	18	26	32	39	48
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	20	14	13	13	12	7	6	1	1	1	1	1
Shares Outstanding	20	14	13	13	12	7	6	1	1	1	1	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-36.46%	-19.54%	196.08%	-	-	-	-	-	-	-	-	-
2025	44.57%	74.46%	22.73%	4.07%	43.16%	19.59%	41.55%	67.68%	107.88%	5.98%	-16.64%	-31.08%
2024	-17.89%	-19.86%	-25.35%	-21.95%	-48.51%	-57.13%	401.79%	339.07%	184.77%	-10.49%	-4.27%	47.38%
2023	-	-	-	-4.99%	-27.47%	-45.52%	41.53%	92.34%	36.43%	12.44%	15.86%	-9.33%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	10.01	2.75	3.88	7.34	11.74	5.22	6.76	2.06	2.82	9.45	10.45	6.30
Quick Ratio	9.78	2.46	3.71	7.19	11.58	5.08	6.43	1.91	2.69	9.14	10.13	6.18
Working Capital	182.81M	41.46M	59.84M	82.42M	98.45M	38.13M	52.27M	9.09M	16.59M	28.17M	34.66M	39.63M
Leverage & Debt
Debt to Equity	0.12	0.60	0.36	0.15	0.09	0.24	0.17	0.92	0.54	0.12	0.10	0.18
Debt Ratio	0.11	0.37	0.26	0.13	0.09	0.19	0.15	0.48	0.35	0.10	0.09	0.16
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Free Cash Flow Per Share TTM	-3.52	-4.28	-3.95	-3.56	-3.15	-5.25	-4.81	-20.36	-21.08	-20.79	-19.81	-15.64
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	107.14%	73.53%	95.54%	51.31%	18.72%	36.00%	12.71%	12.18%	49.45%	77.93%	126.79%	146.95%
EPS Growth (1Y)	24.21%	-17.90%	-3.45%	-82.36%	-85.91%	-69.92%	-74.38%	11.51%	-13.69%	2.70%	8.50%	28.83%
Valuation Metrics
P/E TTM	-4.95	-4.75	-5.09	-3.63	-3.74	-1.17	-4.09	-0.24	-0.55	-0.79	-0.95	-0.79
P/B TTM	2.37	8.56	5.79	2.23	1.61	1.33	2.77	0.87	1.15	0.88	0.85	0.59
Market Cap	435.25M	360.29M	353.10M	187.86M	158.81M	51.07M	145.19M	8.16M	19.57M	25.33M	29.87M	24.02M
Enterprise Value	385.62M	302.06M	276.14M	94.44M	52.66M	5.22M	122.95M	-8.20M	-4.93M	-5.11M	-7.26M	-22.17M
Calculated Values
Free Cash Flow TTM	-72.09M	-59.51M	-51.12M	-44.63M	-38.71M	-34.53M	-30.78M	-29.73M	-30.72M	-30.26M	-28.79M	-22.70M
Net Debt	-49.63M	-58.22M	-76.96M	-93.41M	-106.14M	-45.86M	-22.24M	-16.36M	-24.50M	-30.44M	-37.13M	-46.19M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-30Purchase

Owner: Riley, Antony A

Title: CHIEF FINANCIAL OFFICER

Shares: 9,680

Price/Share: $26.33

Value: $254,874.40

Shares Owned: 41,520

Relationship: Officer

Ownership: Direct

2024-11-21Purchase

Owner: Riley, Antony A

Title: CHIEF FINANCIAL OFFICER

Shares: 22,514

Price/Share: $5.55

Value: $124,952.70

Shares Owned: 30,776

Relationship: Officer

Ownership: Direct

2023-12-18Purchase

Owner: Wagner, Paul A.

Title: See Remarks

Shares: 10,000

Price/Share: $0.75

Value: $7,500.00

Shares Owned: 1,823,236

Relationship: Director,Officer

Ownership: Direct

2023-12-14Purchase

Owner: Wagner, Paul A.

Title: See Remarks

Shares: 10,000

Price/Share: $0.72

Value: $7,200.00

Shares Owned: 1,813,236

Relationship: Director,Officer

Ownership: Direct

2023-12-12Purchase

Owner: Wagner, Paul A.

Title: See Remarks

Shares: 4,776

Price/Share: $0.65

Value: $3,104.40

Shares Owned: 1,792,716

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-30	Riley, Antony A	Officer	CHIEF FINANCIAL OFFICER	Direct	Purchase	9,680	26.33	$254,874.40	41,520	4
2024-11-21	Riley, Antony A	Officer	CHIEF FINANCIAL OFFICER	Direct	Purchase	22,514	5.55	$124,952.70	30,776	4
2023-12-18	Wagner, Paul A.	Director,Officer	See Remarks	Direct	Purchase	10,000	0.75	$7,500.00	1,823,236	4
2023-12-14	Wagner, Paul A.	Director,Officer	See Remarks	Direct	Purchase	10,000	0.72	$7,200.00	1,813,236	4
2023-12-12	Wagner, Paul A.	Director,Officer	See Remarks	Direct	Purchase	4,776	0.65	$3,104.40	1,792,716	4
2023-12-08	Wagner, Paul A.	Director,Officer	See Remarks	Direct	Purchase	15,000	0.62	$9,300.00	1,762,940	4
2023-11-22	Wagner, Paul A.	Director,Officer	See Remarks	Direct	Purchase	400	0.43	$172.00	1,711,737	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

96.38%

Inst. Shares: 13,406,494

Shares Outstanding: 13,910,668

2025-12-31

88.99%

Inst. Shares: 11,522,905

Shares Outstanding: 12,948,308

2025-09-30

82.59%

Inst. Shares: 10,343,866

Shares Outstanding: 12,523,845

2025-06-30

79.87%

Inst. Shares: 9,809,779

Shares Outstanding: 12,282,024

2025-03-31

76.49%

Inst. Shares: 5,034,489

Shares Outstanding: 6,581,667

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	13,406,494	13,910,668	96.38%
2025-12-31	11,522,905	12,948,308	88.99%
2025-09-30	10,343,866	12,523,845	82.59%
2025-06-30	9,809,779	12,282,024	79.87%
2025-03-31	5,034,489	6,581,667	76.49%
2024-12-31	4,275,821	6,393,323	66.88%
2024-09-30	736,627	1,460,007	50.45%
2024-06-30	19,046,381	1,457,695	-
2024-03-31	18,916,569	1,455,795	-
2023-12-31	18,729,572	1,453,402	-
2023-09-30	16,568,936	841,873	-
2023-06-30	3,245,861	841,873	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Forte Biosciences, Inc. (FBRX) — SEC Financial Statements & Analysis

Forte Biosciences, Inc. (FBRX) is a pharmaceutical preparations company, incorporated in DE. Forte Biosciences, Inc. trades on Nasdaq as: FBRX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Forte Biosciences, Inc. reported a Debt-to-Equity ratio of 0.12x, a Price-to-Book (P/B) ratio of 2.37x (TTM), at a market cap of $435.25M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.12x
P/B TTM: 2.37x
Market Cap: $435.25M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Forte Biosciences, Inc. in?

Forte Biosciences, Inc. (FBRX) operates in the Pharmaceutical Preparations industry.

What is FBRX's market cap?

Forte Biosciences, Inc. (FBRX) has a market capitalization of $435.25M as of 2026-06-30.

What exchange does FBRX trade on?

Forte Biosciences, Inc. (FBRX) trades on the Nasdaq.

Where is Forte Biosciences, Inc. incorporated?

Forte Biosciences, Inc. is incorporated in DE.